Peter Curtis-Prior

Cambridge Research Institute Limited (Research charity)
Cambridge Health Limited (Multi level marketing of natural health products)

Degree of Bachelor of Science (BSc, University of London) 1964
Academic Diploma in General Biochemistry (University of London) 1966
Degree of Doctor of Philosophy, Biochemistry Branch (PhD, University of London) 1972
Chartered Biologist and Fellow of the Institute of Biology (C Biol, F I Biol) 1987/1989

Curtis-Prior, P.B., Leslie, S.T., Miller, R.B. and Shill, A.L. Contraceptive composition. European Patent Application Number 87301553.1 (1987), now published under Patent Number EPO 238 218 A1.
Curtis-Prior, P.B., Leslie, S.T., Miller, R.B. and Shill, A.L. Vaginal pharmaceutical composition. European Patent Application Number 87302302.2 (1987) now published under Patent Number EPO 242 980 A2.
Curtis-Prior, P.B. A Review of some computerized methods of neuropsychological assessment. British Journal of Hospital Medicine, 56, 445-449 (1996).

Research & Development of new therapeutic substances from plants.
Neurodegenerative disorders: Neuropsychological Assessment/Application of computerized neuropsychology testing to clinical diagnosis, evaluation of bodily homeostasis and assessment of new therapeutic products in Phases I to IV.
Metabolic Disease States: Chemotherapy of obesity, diabetes mellitus, atherosclerosis, cancer, nutritional and endocrinological disorders.
Cellular Regulation Processes: Biochemical pharmacology of agents active at alpha- and beta-adrenoceptors: hormones, prostanoids, cyclic nucleotides and their phosphodiesterases, adenosine.
Inflammatory Processes: Arthritis, analgesia (narcotics and NSAIDs)/Pyrexia
Eicosanoids (Prostaglandins, leukotrienes and other metabolites of polyunsaturated fatty acids (PUFA), agents which modulate PUFA metabolism.
Physiology, Pathophysiology and Pharmacology of: Adipose tissue, skeletal muscle, airways smooth muscle and blood platelets and aggregation, lung.
Fertility Regulation: Sperm motility in relation to fertility, contraception, premenstrual syndrome, menopause
Secondary Therapeutic Uses: Applications of known drug substances to alternate therapeutic targets, in order to optimize the investment in their research and development.

Progress in the Clinical Development of Aloe vera. London Biotechnology Network Conference: Genesis 2009.
Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function, British Pharmaceutical Conference, Eastbourne, 1998.
Obesity: Research and Reality, "Slimathon '90" meeting, Kettering, 1990.
Bridging the Realization Gap of New Therapeutics. Frost & Sullivan/ Association for the Advancement of British Biotechnology Meeting: 'Biomedical Technology '89,' London, 1989.
From Research to Reality. Committee of Polytechnic Heads of Biological Sciences Meeting, Grantham, 1988.
What Industry Requires from Biochemistry Graduates. UK Biochemical Society, Heads of Departments Meeting, Cambridge, 1986.
Biological Chemistry in Pharmaceutical Development: From Phytopharmacy to Chemotherapy. Royal Society of Chemistry Meeting, Cambridge, 1986.

Anglia Ruskin University